| Breakdown | TTM | Dec 2025 | Dec 2023 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 6.37B | 6.35B | 8.65B | 6.99B | 5.84B | 3.66B |
| Gross Profit | 2.07B | 2.10B | 2.60B | 2.39B | 1.43B | 1.09B |
| EBITDA | 1.15B | 1.31B | 1.12B | 1.33B | 308.21M | 259.67M |
| Net Income | 538.98M | 506.01M | 734.58M | 874.21M | 99.56M | 87.76M |
Balance Sheet | ||||||
| Total Assets | 0.00 | 6.15B | 4.82B | 5.60B | 4.31B | 3.98B |
| Cash, Cash Equivalents and Short-Term Investments | 1.90B | 2.42B | 1.55B | 1.56B | 555.26M | 841.13M |
| Total Debt | 0.00 | 449.00M | 422.75M | 340.41M | 614.55M | 655.74M |
| Total Liabilities | -4.26B | 1.89B | 1.80B | 1.77B | 1.99B | 1.72B |
| Stockholders Equity | 4.26B | 4.26B | 3.02B | 3.83B | 2.32B | 2.26B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -13.66M | 837.30M | 527.37M | 101.69M | -65.61M |
| Operating Cash Flow | 0.00 | 449.50M | 903.58M | 783.16M | 195.06M | 144.23M |
| Investing Cash Flow | 0.00 | -447.54M | -627.42M | -589.70M | -57.54M | -159.18M |
| Financing Cash Flow | 0.00 | -1.67M | -275.94M | -194.50M | -136.79M | 14.41M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | ₹3.77B | 19.57 | ― | ― | 8.41% | 8.81% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
61 Neutral | ₹2.35B | 5.00 | ― | 1.72% | 6.00% | -19.96% | |
59 Neutral | ₹2.30B | 14.18 | ― | 0.33% | 15.16% | 780.57% | |
58 Neutral | ₹2.61B | 59.32 | ― | ― | -1.97% | -44.80% | |
47 Neutral | ₹1.95B | 13.75 | ― | ― | -8.50% | ― | |
47 Neutral | ₹1.74B | -6.52 | ― | ― | -0.90% | -304.07% |
Shreyans Industries Limited has announced the closure of its trading window for dealings in its securities from 1 January 2025 until 48 hours after the declaration of its unaudited financial results for the quarter and nine months ended 31 December 2025. The restriction, applicable to promoters, directors, key managerial personnel, designated and connected persons and their immediate relatives, is in line with SEBI’s Prohibition of Insider Trading Regulations, underscoring the company’s adherence to regulatory norms on unpublished price-sensitive information and safeguarding market integrity for investors.